Imaging With a New Agent That Finds a Cancer Protein Called HER2
Clinical trial NCT03109977 · COMPLETED
Trial details
- NCT number
- NCT03109977
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-31
- Primary completion
- 2018-04-12
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.